Skip to main

Scheduled Maintenance - Tuesday 30 December 2025 from 8pm AEST

Maintenance is scheduled between 8.00 - 11.30 pm AEST, Tuesday 30 December 2025 and the site may be unavailable or slow during this time.

Designation of Bevacizumab (Avastin) as an orphan drug - Roche Products Pty Ltd

This item is authorised by the following title:

Latest version
C2017G0004313 January 2017

Legislation text